Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Merck & Co. describes new oxysterols receptor LXR-beta agonists

June 9, 2017

Iproteos discovers novel matrix metalloproteinase-2/9 inhibitors

June 9, 2017

Merck & Co. discloses novel HIV integrase inhibitors

June 8, 2017

Bristol-Myers Squibb patents TYK2 inhibitors

June 8, 2017

Actelion identifies prostanoid EP2/EP4 receptor antagonists

June 8, 2017

Neuform Pharmaceuticals divulges new PI3Kdelta inhibitors

June 8, 2017

New MAPK 1 inhibtors patented by AstraZeneca

June 8, 2017

Novartis discovers novel MALT1 inhibitors

June 8, 2017

R-Pharm CJSC discloses new tyrosine-protein kinase JAK inhibitors

June 7, 2017

CIMA describes novel DNMT/EHMT2 inhibitors

June 7, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...